title: Increased serum flt3-ligand in healthy donors undergoing granulocyte colony-stimulating factor-induced peripheral stem cell mobilization.
abstract: The effect of granulocyte colony-stimulating factor (G-CSF) induced mobilization of peripheral blood progenitor cells (PBPC) on the endogenous serum levels of cytokines stem cell factor (SCF) and flt3-ligand (flt3-L) was studied in 18 healthy subjects undergoing allogeneic PBPC donation. Donors received a standardized mobilization regime consisting of a 4-day course of G-CSF, with leukapheresis on day 5. Endogenous serum flt3-L and SCF were determined prior to G-CSF administration, on the day of leukapheresis, and followed up until day +100 after cessation of G-CSF administration. The administration of G-CSF resulted in a transient elevation of endogenous flt3-L serum levels. At the day of leukapheresis serum flt3-L showed a median increase of 75% compared to serum flt3-L levels obtained before G-CSF treatment. The increase in serum flt3-L levels showed no correlation with the total number of progenitor cells mobilized. Cessation of G-CSF treatment led to normalization of serum flt3-L within 7 days post G-CSF administration. In contrast, serum CSF levels remained unchanged in response to G-CSF administration. Our results demonstrate a transient surge in serum flt3-L in relation to G-CSF-induced PBPC mobilization, although the assessment of endogenous flt3-L give no information regarding the ability for G-CSF-induced PBPC recruitment in healthy individuals.
authors.affiliation: Department of Blood Group Serology and Transfusion Medicine, Bone Marrow Transplantation Unit, University Hospital of Vienna, Vienna, Austria. markus.dettke@univie.ac.at
authors.forename: M
authors.initials: M
authors.lastname: Dettke
authors.forename: S
authors.initials: S
authors.lastname: Jurko
authors.forename: B M
authors.initials: BM
authors.lastname: Rüger
authors.forename: G
authors.initials: G
authors.lastname: Leitner
authors.forename: H T
authors.initials: HT
authors.lastname: Greinix
authors.forename: P
authors.initials: P
authors.lastname: Kalhs
authors.forename: M B
authors.initials: MB
authors.lastname: Fischer
authors.forename: P
authors.initials: P
authors.lastname: Höcker
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006410:Hematopoiesis; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D006801:Humans; D007937:Leukapheresis; D019520:Living Donors; D008297:Male; D008565:Membrane Proteins / Q000097:blood*; D008875:Middle Aged; D011994:Recombinant Proteins; D019089:Stem Cell Factor / Q000097:blood; D013997:Time Factors
chemical_list: D008565:Membrane Proteins; D011994:Recombinant Proteins; D019089:Stem Cell Factor; C084881:flt3 ligand protein; D016179:Granulocyte Colony-Stimulating Factor